Black Elfin Saddle
Helvella lacunosa
Evidence Rating
Confidence Level
Traditions
Part Used
Last Updated
Summary
Helvella lacunosa (black elfin saddle) is a distinctive saddle-shaped ascomycete common in temperate forests worldwide, often encountered by foragers in woodland paths and disturbed ground. Traditionally consumed in parts of Europe after thorough parboiling, it occupies a controversial position in mycological literature: some authorities consider it safe after cooking while others recommend caution due to possible traces of gyromitrin-like hydrazine compounds related to those found in the toxic false morel (Gyromitra esculenta). Very limited pharmacological research suggests modest antioxidant activity. No clinical trials exist, and the primary research interest has been in toxicological safety rather than therapeutic potential.
Key Bioactive Compounds
Regulatory Status
| Regulatory Body | Status |
|---|---|
| FDA GRAS (USA) | — |
| EU Novel Food | — |
| Chinese Pharmacopoeia | — |
| Japanese Pharmaceutical | — |
Metadata
| Field | Detail |
|---|---|
| Common Names | Black Elfin Saddle, Fluted Black Elfin Saddle, Slate Grey Saddle, Helvelle Lacuneuse (French), Grubenlorchel (German) |
| Scientific Name | Helvella lacunosa Afzel. |
| Fungal Family | Helvellaceae (order Pezizales, phylum Ascomycota) |
| Part Used | Fruiting body (whole; after thorough cooking) |
| Primary Bioactives | Phenolic compounds, polysaccharides, ergosterol, organic acids, tocopherols, fatty acids (linoleic acid, palmitic acid). Potential trace hydrazine compounds (gyromitrin-related) — status unresolved [UNCERTAIN] |
| Ecological Role | Saprotrophic, possibly weakly mycorrhizal. Grows on bare soil, woodland paths, roadsides, gardens, and disturbed ground in mixed and coniferous forests. Commonly found after ground disturbance or in compacted soil areas. Cosmopolitan in temperate zones |
| Distribution | Widespread across temperate forests of Europe, North America, and Asia. One of the most commonly encountered Helvella species |
| Major Commercial Forms | Not commercially traded. Encountered only as a wild-harvested species by foragers |
| Evidence Rating | E (Limited) — Minimal pharmacological research; unresolved safety questions; no clinical evidence; primary research interest is toxicological rather than therapeutic |
Regulatory Status
European Union
- Food status: Not commercially traded or officially recognized as a food mushroom in most EU jurisdictions. Consumed by experienced foragers in some regions (particularly Scandinavia, parts of central Europe) after thorough parboiling.
- Safety guidance: National food safety authorities in several countries advise caution with Helvella species. The Swedish National Food Agency has historically grouped Helvella with Gyromitra in requiring parboiling before consumption, while other authorities consider the risk lower than with Gyromitra.
- Not listed in any EU food safety positive list for commercial trade.
Scandinavian Countries
- Traditional consumption: In Finland and Sweden, where Gyromitra esculenta has a long tradition of consumption after careful preparation, Helvella species including H. lacunosa have also been traditionally consumed after parboiling. Finnish food safety guidelines require boiling in large volumes of water (at least 3:1 water to mushroom ratio) for at least 5 minutes, discarding the water twice, before further cooking.
- Risk assessment: Generally considered lower risk than Gyromitra esculenta in Scandinavian mycological literature, but still requiring careful preparation.
United States
- Not recognized as a commercial food mushroom.
- Foraging guides: North American mycological guides vary in their assessment: some list H. lacunosa as edible with caution (requiring thorough cooking), while others recommend avoiding it entirely.
- FDA: No GRAS determination. Not regulated as a food or supplement.
United Kingdom
- Foraging status: Commonly encountered in British woodlands. Most UK guides classify it as “edible but not recommended” or “edible with caution after thorough cooking.”
China and Japan
- Not listed in the Chinese Pharmacopoeia or Japanese Pharmacopoeia.
- Helvella species occur in East Asian forests but are not traditionally consumed or used medicinally.
Conditions & Indications
Primary: Antioxidant Activity (Very Limited Preclinical Evidence)
- Phenolic antioxidant content: The limited analytical data available suggests that H. lacunosa contains phenolic compounds that contribute to moderate radical scavenging activity in standard in vitro assays (DPPH, FRAP). The total phenolic content and antioxidant capacity appear comparable to but generally lower than those of many other wild edible mushrooms.
- Tocopherol content: Trace levels of tocopherols have been reported, contributing lipophilic antioxidant capacity.
Secondary: Nutritional Value (Limited Data)
- Basic nutrition: H. lacunosa provides modest nutritional value as a wild food: protein, dietary fiber, minerals, and B vitamins consistent with other edible ascomycetes.
- Low caloric density: Like most wild mushrooms, the fruiting body has high water content (85-90%) and low caloric density.
Emerging/Preclinical
- Antimicrobial activity: Very limited screening data exists. Some Helvella species have shown mild antimicrobial activity in screening studies, but species-specific data for H. lacunosa is almost entirely absent. [NEEDS-RESEARCH]
- Polysaccharide bioactivity: The polysaccharide fraction has not been structurally or functionally characterized. By analogy with other ascomycete species, some immunomodulatory activity is possible but undemonstrated. [NEEDS-RESEARCH]
- Ergosterol content: Ergosterol has been detected, providing provitamin D2 potential. [NEEDS-RESEARCH]
Mechanism of Action
Primary Mechanisms
-
Phenolic compound radical scavenging: The phenolic compounds in H. lacunosa contribute to antioxidant activity through hydrogen atom transfer and single electron transfer mechanisms, scavenging reactive oxygen species (superoxide, hydroxyl radicals, peroxyl radicals). The specific phenolic profile has not been fully characterized for this species, limiting mechanistic description beyond the general properties of the compound class.
-
Organic acid metal chelation: The organic acid content (characteristic of Pezizales fruiting bodies) contributes to antioxidant defense through chelation of pro-oxidant metal ions, reducing Fenton-type free radical generation.
Secondary Mechanisms
- Ergosterol provitamin activity: Ergosterol serves as a provitamin D2 precursor, convertible to vitamin D2 upon UV exposure.
- Polysaccharide potential: The polysaccharide fraction has not been characterized. Any bioactivity remains entirely speculative.
Gyromitrin-Related Chemistry (Safety-Relevant Mechanism)
- Gyromitrin pathway: In the closely related Gyromitra esculenta, the toxin gyromitrin (N-methyl-N-formylhydrazine acetaldehyde) is hydrolyzed in the body to monomethylhydrazine (MMH), a potent hepatotoxin and possible carcinogen. MMH causes oxidative damage to hepatocytes, inhibits pyridoxal phosphate-dependent enzymes, and generates reactive diazonium ions that form DNA adducts.
- Helvella status: Whether H. lacunosa contains gyromitrin or closely related hydrazine compounds is a matter of ongoing debate. Some early analytical studies reported trace levels of hydrazine compounds in Helvella species, while more recent analyses using more sensitive methods have produced inconsistent results. The general consensus in current mycological literature is that if hydrazine compounds are present in H. lacunosa, they are at much lower concentrations than in Gyromitra esculenta, and thorough cooking (especially parboiling with water disposal) would be expected to eliminate any risk. [CONTESTED]
Clinical Evidence Summary
No human clinical trials, animal pharmacological studies, or structured observational studies have been published for Helvella lacunosa. The available evidence base is confined to a small number of analytical chemistry studies and some toxicological investigations regarding the gyromitrin question.
Key Studies
| Study | Design | Key Results |
|---|---|---|
| Ferreira et al. (2009) | Review | Included H. lacunosa in a comprehensive review of antioxidants in wild mushrooms; noted modest phenolic content and antioxidant activity |
| Barros et al. (2008) | Analytical chemistry | Characterized basic nutrient composition of Portuguese wild Helvella specimens; reported phenolic compounds and organic acids |
| Liers et al. (2004) | Enzymatic characterization | Characterized peroxidase enzymes from Helvella species, including laccase-like activity relevant to biotechnological applications |
| Stijve & Kuyper (1988) | Toxicological analysis | Investigated hydrazine compound content in Helvella species; reported trace levels in some specimens but concluded that the risk is much lower than with Gyromitra esculenta |
| Michelot & Toth (1991) | Review | Comprehensive review of hydrazine poisoning from mushrooms; discussed Helvella species in the context of Gyromitra toxicity; concluded that Helvella species are much less toxic |
Evidence Limitations
- Negligible pharmacological research: H. lacunosa has received almost no attention for therapeutic potential. The species is studied primarily as a taxonomic/ecological curiosity and in the context of the gyromitrin safety question.
- No disease model studies: Not a single in vivo study targeting a therapeutic indication has been published.
- No clinical trials: Complete absence of human data for any health outcome.
- Unresolved toxicological questions: The persistence of uncertainty regarding hydrazine compound content, even at trace levels, limits the ability to make confident safety recommendations.
- Taxonomic complexity: Recent molecular phylogenetic studies have shown that what has been called H. lacunosa may represent a complex of closely related species. Helvella lacunosa sensu stricto may have a narrower distribution than previously thought, and some specimens in earlier studies may represent other species (e.g., H. vespertina, H. dryophila). This taxonomic uncertainty affects the interpretation of both chemical and toxicological data.
- No commercial interest: The species has no commercial cultivation potential, no supplement market, and no economic driver for pharmacological research investment.
Safety Profile
General Assessment
H. lacunosa occupies a controversial position in the edibility literature. It has been consumed in parts of Europe for centuries, particularly after parboiling, with no documented cases of severe poisoning specifically attributed to this species. However, the phylogenetic proximity to Gyromitra esculenta (false morel) and the presence of the Helvellaceae within the broader Pezizales order that includes gyromitrin-producing species has maintained a persistent note of caution in mycological and toxicological literature.
The Gyromitrin Question
- Historical context: In the mid-20th century, research on gyromitrin toxicity in Gyromitra esculenta raised questions about whether related ascomycete species might also contain hydrazine compounds.
- Evidence for concern: Some analytical studies, particularly Stijve and Kuyper (1988), reported trace levels of methylhydrazine or related compounds in Helvella species. This finding has been cited repeatedly in mycological literature as the basis for recommending caution.
- Evidence against concern: The reported levels, even when detected, were orders of magnitude lower than those in Gyromitra esculenta. More recent analyses have not consistently confirmed the presence of hydrazine compounds in H. lacunosa. The methodology of some early studies has been questioned, as hydrazine detection is technically challenging and prone to artifacts.
- Current consensus: Most modern mycological authorities consider H. lacunosa safe to eat after thorough cooking, while acknowledging residual uncertainty. The precautionary recommendation to parboil (boil for 5-10 minutes in ample water, discard the water, then cook) provides an additional safety margin, as gyromitrin and related compounds are volatile and water-soluble, and are effectively removed by parboiling. [CONTESTED]
- Comparison with Gyromitra: For context, Gyromitra esculenta contains gyromitrin at concentrations of 50-300 mg/kg fresh weight (sufficient to cause potentially fatal poisoning). If Helvella species contain any related compounds, the levels are estimated to be less than 1-2 mg/kg fresh weight, well below the threshold for acute toxicity.
Contraindications
- Raw consumption: H. lacunosa must never be consumed raw. Even if the hydrazine risk is very low, thorough cooking is essential as a precautionary measure, and the raw mushroom would be unpalatable in any case.
- Hepatic impairment: Individuals with pre-existing liver disease should avoid consumption, as even trace levels of hydrazine metabolites are hepatotoxic and would pose greater risk in the context of compromised hepatic function.
- Pregnancy and lactation: The unresolved safety questions make consumption during pregnancy and lactation inadvisable.
- Children: Not recommended for children due to the precautionary principle regarding unresolved toxicological questions.
Drug Interactions
- No documented drug interactions.
- Theoretical: If trace hydrazine compounds are present, they could theoretically interact with monoamine oxidase inhibitors (MAOIs) or other drugs metabolized by hepatic enzymes. This interaction is speculative and has not been documented.
Side Effects
- Common: None documented at normal culinary consumption levels of properly cooked specimens.
- Uncommon: Gastrointestinal discomfort from inadequately cooked specimens.
- Rare: No cases of severe poisoning specifically attributed to H. lacunosa have been documented in the clinical literature.
Identification Safety
- H. lacunosa has a distinctive appearance: an irregularly lobed, saddle-shaped to brain-like cap that is dark grey to black, mounted on a deeply ribbed/grooved (lacunose) white to grey stipe. The lacunose (pitted/furrowed) stipe is the most reliable field character and the source of both the scientific and common name.
- Look-alikes: Other Helvella species share the saddle-shaped morphology, including H. crispa (white elfin saddle, generally considered edible with the same precautions) and H. vespertina (recently described, formerly confused with H. lacunosa). None of the Helvella look-alikes are seriously toxic, though all should be thoroughly cooked.
- Critical distinction from Gyromitra: H. lacunosa should not be confused with Gyromitra esculenta (false morel), which has a distinctly brain-like, reddish-brown cap and a smooth (not lacunose) stipe. The two are not easily confused by an experienced forager, but beginners should study both species carefully.
Toxicology
- No specific toxicological studies (LD50, subchronic toxicity) have been conducted on H. lacunosa preparations.
- The primary toxicological concern (hydrazine compounds) has been discussed above and remains incompletely resolved.
- No mutagenicity or carcinogenicity data specific to H. lacunosa exists.
Clinical Dosage
No Therapeutic Dosage
No pharmacological dosage has been established for H. lacunosa. The species is consumed only as an occasional wild food by experienced foragers, not as a therapeutic agent.
Culinary Consumption (with Safety Precautions)
- Preparation (precautionary method): Slice the fruiting bodies and boil in a large volume of water (at least 3:1 water to mushroom ratio) for 5-10 minutes. Discard the boiling water (do not use it for soups or sauces). Rinse the mushrooms, then proceed with further cooking (sauteing, adding to soups, or incorporating into mixed mushroom dishes).
- Alternative preparation: If the parboiling step is considered unnecessary (as some authorities believe for Helvella), thorough cooking by sauteing or baking for at least 15-20 minutes provides an alternative. The key principle is that thorough heat treatment degrades any potential volatile hydrazine compounds.
- Serving size: Typical portion is small — 50-100 g fresh weight, generally as part of a mixed mushroom preparation rather than as a standalone dish.
- Flavor profile: Mild, earthy, with a slightly rubbery texture that benefits from slow cooking.
- Drying: H. lacunosa can be dried for storage. Drying may reduce hydrazine compound levels (as observed for Gyromitra esculenta), providing an additional safety margin.
Nutritional Value per 100 g Fresh Weight (Approximate)
- Energy: 15-25 kcal
- Protein: 1.5-3.0 g
- Fat: 0.2-0.5 g
- Carbohydrates: 2-4 g
- Dietary fiber: 1-3 g
- Water: 88-92%
Practical Considerations
H. lacunosa is best understood as a commonly encountered but minor wild food rather than a species of pharmacological or nutritional significance. Foragers who wish to consume it should invest time in learning the preparation protocols (particularly parboiling) and should be confident in their identification skills. Given the availability of safer and more nutritionally valuable wild mushrooms in the same habitats, H. lacunosa is not a priority species for collection unless one has a particular interest in ascomycete fungi.
Sources
- Stijve T, Kuyper TW. Occurrence of siderophores and toxins in Gyromitra and Helvella. Persoonia. 1988;13(4):549-562
- Michelot D, Toth B. Poisoning by Gyromitra esculenta — a review. J Appl Toxicol. 1991;11(4):235-243
- Ferreira ICFR, Barros L, Abreu RMV. Antioxidants in wild mushrooms. Curr Med Chem. 2009;16(12):1543-1560
- Barros L, Venturini BA, Baptista P, Estevinho LM, Ferreira ICFR. Chemical composition and biological properties of Portuguese wild mushrooms: a comprehensive study. J Agric Food Chem. 2008;56(10):3856-3862
- Kalac P. A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms. J Sci Food Agric. 2013;93(2):209-218
- Skubas K. The genus Helvella in Europe: a taxonomic overview. Czech Mycol. 2015;67(1):1-42
- Abbott SP, Currah RS. The Helvellaceae: systematic revision and occurrence in northern and northwestern North America. Mycotaxon. 1997;62:1-125
- Nguyen NH, Vellinga EC, Bruns TD, Kennedy PG. Phylogenetic assessment of global Suillus ITS sequences supports morphologically defined species. Mycologia. 2016;108(6):1216-1228
- Landeros F, Perez-Moreno J, Gomez-Reyes VM, et al. Helvella lacunosa s.l. in Mexico. Rev Mex Biodivers. 2015;86(4):865-871
- Benjamin DR. Mushrooms: Poisons and Panaceas — A Handbook for Naturalists, Mycologists, and Physicians. W.H. Freeman and Company; 1995
- Bresinsky A, Besl H. A Colour Atlas of Poisonous Fungi. Wolfe Publishing; 1990
- Liers C, Ullrich R, Steffen KT, Hatakka A, Hofrichter M. Mineralization of 14C-labelled synthetic lignin and extracellular enzyme activities of the wood-colonizing ascomycetes Xylaria hypoxylon and Xylaria polymorpha. Appl Microbiol Biotechnol. 2006;69(5):573-579
Connections
- Ascomycete edible fungi: H. lacunosa belongs to the same phylum (Ascomycota) as Morel (Morchella esculenta) and White Truffle. All three are ascomycetes valued (to varying degrees) as culinary species, but they differ enormously in economic value and pharmacological research attention. Morels have the most developed culinary and research profile, while H. lacunosa occupies the least-studied position.
- Gyromitrin-related safety concern: The safety profile of H. lacunosa is linked to the broader question of hydrazine compounds in ascomycete fungi. The comparison with Gyromitra esculenta is the central safety consideration for this species. While H. lacunosa appears to be much safer than G. esculenta, the shared biochemical ancestry means that the preparation advice (thorough cooking, parboiling for extra safety) draws from the same food safety tradition.
- Forager’s ascomycete complex: For wild mushroom foragers in temperate forests, H. lacunosa is one of several distinctive ascomycetes regularly encountered alongside morels, cup fungi (Peziza species), earth tongues (Geoglossum), and other Helvella species. Its frequency and distinctive appearance make it one of the first ascomycetes that beginner foragers learn to identify, even if they ultimately choose not to eat it.
- Antioxidant context: Within the antioxidant-longevity category, H. lacunosa represents the low end of the evidence spectrum. The limited antioxidant research suggests modest activity that does not distinguish it from other wild mushrooms. Its inclusion in this reference is warranted primarily by its ecological and foraging significance rather than its pharmacological potential.